The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
about
Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.Differential Co-expression and Regulatory Network Analysis Uncover the Relapse Factor and Mechanism of T Cell Acute Leukemia.
P2860
The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The Wilms' tumor suppressor WT ...... ell death in leukemic T cells.
@en
The Wilms' tumor suppressor WT ...... ell death in leukemic T cells.
@nl
type
label
The Wilms' tumor suppressor WT ...... ell death in leukemic T cells.
@en
The Wilms' tumor suppressor WT ...... ell death in leukemic T cells.
@nl
prefLabel
The Wilms' tumor suppressor WT ...... ell death in leukemic T cells.
@en
The Wilms' tumor suppressor WT ...... ell death in leukemic T cells.
@nl
P2093
P2860
P356
P1476
The Wilms' tumor suppressor WT ...... cell death in leukemic T cells
@en
P2093
Konstantina Bourkoula
Marco Giaisi
Min Li-Weber
Peter H Krammer
Rebecca Köhler
P2860
P304
P356
10.1002/IJC.28379
P577
2013-08-09T00:00:00Z